Literature DB >> 25859165

A review of the treatment of type 2 diabetes in children.

Erin St Onge1, Shannon A Miller1, Carol Motycka2, Adrienne DeBerry3.   

Abstract

The incidence of type 2 diabetes and obesity in children and adolescents has risen at staggering rates. Studies have shown that treating type 2 diabetes with oral medications in children may be more difficult than treating in adults. Compounding this problem is the fact that most of the medications available for treating type 2 diabetes have not been studied in children. Recently, the American Diabetes Association and the Pediatric Endocrine Society have collaborated to create a guideline for the treatment of type 2 diabetes in children. Similar to the treatment of adults with type 2 diabetes, metformin remains the mainstay of therapy along with diet and exercise. Adjunctive therapy should be based on the limited clinical evidence available as well as on patient preference. In order to avoid detrimental microvascular and macrovascular complications, patients, clinicians, and family members should work together to ensure adequate treatment of type 2 diabetes in children.

Entities:  

Keywords:  adolescents; children; guidelines; treatment; type 2 diabetes

Year:  2015        PMID: 25859165      PMCID: PMC4353199          DOI: 10.5863/1551-6776-20.1.4

Source DB:  PubMed          Journal:  J Pediatr Pharmacol Ther        ISSN: 1551-6776


  53 in total

1.  Glimepiride treatment and IGF-I in adolescents with type 1 diabetes: a prospective, randomized, double-blind, placebo-controlled study.

Authors:  Stefan A Wudy; Josef Högel; Barbara Dollinger; Primus Mullis; Eberhard Heinze
Journal:  Diabetes Care       Date:  2003-04       Impact factor: 19.112

2.  Time to failure of oral therapy in children with type 2 diabetes: a single center retrospective chart review.

Authors:  Nicole S Barnes; Perrin C White; Michele R Hutchison
Journal:  Pediatr Diabetes       Date:  2012-05-31       Impact factor: 4.866

Review 3.  The global spread of type 2 diabetes mellitus in children and adolescents.

Authors:  Orit Pinhas-Hamiel; Philip Zeitler
Journal:  J Pediatr       Date:  2005-05       Impact factor: 4.406

4.  Childhood obesity, other cardiovascular risk factors, and premature death.

Authors:  Paul W Franks; Robert L Hanson; William C Knowler; Maurice L Sievers; Peter H Bennett; Helen C Looker
Journal:  N Engl J Med       Date:  2010-02-11       Impact factor: 91.245

5.  Prevalence of obesity and trends in body mass index among US children and adolescents, 1999-2010.

Authors:  Cynthia L Ogden; Margaret D Carroll; Brian K Kit; Katherine M Flegal
Journal:  JAMA       Date:  2012-01-17       Impact factor: 56.272

Review 6.  Sitagliptin: a dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes.

Authors:  Shannon Miller; Erin L St Onge
Journal:  Ann Pharmacother       Date:  2006 Jul-Aug       Impact factor: 3.154

7.  Prevalence and trends in overweight among US children and adolescents, 1999-2000.

Authors:  Cynthia L Ogden; Katherine M Flegal; Margaret D Carroll; Clifford L Johnson
Journal:  JAMA       Date:  2002-10-09       Impact factor: 56.272

8.  Twenty-four-hour simultaneous subcutaneous Basal-bolus administration of insulin and amylin in adolescents with type 1 diabetes decreases postprandial hyperglycemia.

Authors:  Rubina A Heptulla; Luisa M Rodriguez; Kimberly J Mason; Morey W Haymond
Journal:  J Clin Endocrinol Metab       Date:  2009-02-03       Impact factor: 5.958

9.  Effect of pramlintide on prandial glycemic excursions during closed-loop control in adolescents and young adults with type 1 diabetes.

Authors:  Stuart A Weinzimer; Jennifer L Sherr; Eda Cengiz; Grace Kim; Jessica L Ruiz; Lori Carria; Gayane Voskanyan; Anirban Roy; William V Tamborlane
Journal:  Diabetes Care       Date:  2012-07-18       Impact factor: 19.112

10.  Banting Lecture. From the triumvirate to the ominous octet: a new paradigm for the treatment of type 2 diabetes mellitus.

Authors:  Ralph A Defronzo
Journal:  Diabetes       Date:  2009-04       Impact factor: 9.461

View more
  10 in total

1.  Prevention of diabetes in overweight/obese children through a family based intervention program including supervised exercise (PREDIKID project): study protocol for a randomized controlled trial.

Authors:  Lide Arenaza; María Medrano; María Amasene; Beatriz Rodríguez-Vigil; Ignacio Díez; Manuel Graña; Ignacio Tobalina; Edurne Maiz; Edurne Arteche; Eider Larrarte; Inge Huybrechts; Catherine L Davis; Jonatan R Ruiz; Francisco B Ortega; Javier Margareto; Idoia Labayen
Journal:  Trials       Date:  2017-08-10       Impact factor: 2.279

Review 2.  Consensus Recommendations on Sulfonylurea and Sulfonylurea Combinations in the Management of Type 2 Diabetes Mellitus - International Task Force.

Authors:  Sanjay Kalra; Silver Bahendeka; Rakesh Sahay; Sujoy Ghosh; Fariduddin Md; Abbas Orabi; Kaushik Ramaiya; Sameer Al Shammari; Dina Shrestha; Khalid Shaikh; Sachitha Abhayaratna; Pradeep K Shrestha; Aravinthan Mahalingam; Mazen Askheta; Aly Ahmed A Rahim; Fatimah Eliana; Hari K Shrestha; Sandeep Chaudhary; Nancy Ngugi; Jean Claude Mbanya; Than Than Aye; Tint Swe Latt; Zhanay A Akanov; Abbas Raza Syed; Nikhil Tandon; A G Unnikrishnan; S V Madhu; Ali Jawa; Subhankar Chowdhury; Sarita Bajaj; Ashok Kumar Das
Journal:  Indian J Endocrinol Metab       Date:  2018 Jan-Feb

3.  Retrospective Evaluation of Metformin and/or Metformin Plus a New Polysaccharide Complex in Treating Severe Hyperinsulinism and Insulin Resistance in Obese Children and Adolescents with Metabolic Syndrome.

Authors:  Stefano Stagi; Franco Ricci; Martina Bianconi; Maria Amina Sammarco; Giovanna Municchi; Sonia Toni; Lorenzo Lenzi; Alberto Verrotti; Maurizio de Martino
Journal:  Nutrients       Date:  2017-05-20       Impact factor: 5.717

Review 4.  New Insights about How to Make an Intervention in Children and Adolescents with Metabolic Syndrome: Diet, Exercise vs. Changes in Body Composition. A Systematic Review of RCT.

Authors:  Enrique Albert Pérez; Victoria Mateu Olivares; Rosa María Martínez-Espinosa; Mariola D Molina Vila; Manuel Reig García-Galbis
Journal:  Nutrients       Date:  2018-07-06       Impact factor: 5.717

5.  Prevalence and correlates of overweight and obesity among school children in an urban district in Ghana.

Authors:  Theodosia Adom; Anniza De Villiers; Thandi Puoane; André Pascal Kengne
Journal:  BMC Obes       Date:  2019-04-01

6.  Endocrinal dysfunction in children with Down syndrome.

Authors:  Kotb Abbass Metwalley; Hekma Saad Farghaly
Journal:  Ann Pediatr Endocrinol Metab       Date:  2022-03-31

Review 7.  Drug dosing in children with obesity: a narrative updated review.

Authors:  Francesca Gaeta; Valeria Conti; Angela Pepe; Pietro Vajro; Amelia Filippelli; Claudia Mandato
Journal:  Ital J Pediatr       Date:  2022-09-08       Impact factor: 3.288

8.  Pharmacotherapy in paediatric type 2 diabetes mellitus: a protocol for a systematic review and network meta-analysis of randomised trials.

Authors:  Fangwen Zhou; Jiawen Deng; Laura Banfield; Lehana Thabane; Behnam Sadeghirad; M Constantine Samaan
Journal:  BMJ Open       Date:  2022-09-26       Impact factor: 3.006

9.  Metformin-induced suppression of Nemo-like kinase improves erythropoiesis in preclinical models of Diamond-Blackfan anemia through induction of miR-26a.

Authors:  Mark C Wilkes; Kavitha Siva; Gianluca Varetti; Jacqueline Mercado; Ethan P Wentworth; Cristina A Perez; Mallika Saxena; Sharon Kam; Simryn Kapur; Jun Chen; Anu Narla; Bert Glader; Shou Lin; Manuel Serrano; Johan Flygare; Kathleen M Sakamoto
Journal:  Exp Hematol       Date:  2020-09-12       Impact factor: 3.084

10.  Treatment of diabetes in children.

Authors:  Yi-Qing Gao; Min Gao; Ying Xue
Journal:  Exp Ther Med       Date:  2016-01-29       Impact factor: 2.447

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.